Cargando…
Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy
ADPKD and ARPKD are a significant cause of morbidity and mortality in children and young adults. ADPKD with an incidence of 1:400–1,000 affects over 13 million individuals worldwide, and is a major cause of end-stage renal disease (ESRD) in adults. However, symptomatic disease is increasingly recogn...
Autores principales: | Sweeney, William E., Avner, Ellis D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953890/ https://www.ncbi.nlm.nih.gov/pubmed/24336431 http://dx.doi.org/10.1038/pr.2013.191 |
Ejemplares similares
-
Emerging Therapies for Childhood Polycystic Kidney Disease
por: Sweeney, William E., et al.
Publicado: (2017) -
Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease
por: Sweeney, William E, et al.
Publicado: (2017) -
Unique interstitial miRNA signature drives fibrosis in a murine model of autosomal dominant polycystic kidney disease
por: Patil, Ameya, et al.
Publicado: (2018) -
Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment
por: Halvorson, Christian R, et al.
Publicado: (2010) -
Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease
por: Cordido, Adrian, et al.
Publicado: (2021)